California Proposition 38: Immunology research bonds
California · Statutory measure · Health · Statewide decision
Explanation reviewed 2026-10-27. AI-written and checked against linked official evidence; not an election-office summary.
AI-written summary
Would authorize $8.4 billion in bonds, split between a qualifying UC-affiliated nonprofit institute and competitive grants. At least half supports cancer, heart-disease and Alzheimer’s research. It requires reporting, state revenue sharing and generally a 20% California discount on resulting treatments.
What applies now
California has issued bonds for other medical research, but this proposed immunology and immunotherapy authorization is new.
If yes / for
Authorize the bonds and research framework.
If no / against
Do not authorize this new borrowing.
Costs and funding
Estimated General Fund repayments of $500 million–$600 million annually for about 20 years. Research revenue could offset costs over later decades, but is uncertain.
Timing
Implementation date not independently established in this baseline.
Passage rule
A majority of votes cast on the proposition.
Some official sources do not have comparable automated archives. Consult the linked evidence and its review date.